In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
Rachael Buck, PhD, discusses the potential of a new infant formula she and her research team developed, which harnesses the unique qualities and benefits of human milk oligosaccharides (an alternative...
Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults with AATD has...
Bruce Given, MD, discusses alpha-1 antitrypsin deficiency (AATD) treatment methods, including enzyme therapy and gene therapy, and the hope that advancements in replacement therapy will improve treatments...
